Plasma Apheresis Machines Market Growing at CAGR — 2026 Report

Plasma Apheresis Machines by Application (Hospitals, Blood Centers, Others), by Types (Desktop Type, Trolley Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $3500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $3500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Plasma Apheresis Machines Market Overview

Plasma apheresis machines are specialized medical devices that separate plasma from whole blood for therapeutic and manufacturing purposes, playing a pivotal role in treating autoimmune disorders and supporting plasma‑derived biopharmaceuticals. The Plasma Apheresis Machines market size was estimated at approximately USD 2.2 billion in 2022, with a growth outlook driven by rising prevalence of chronic diseases, expanding plasma‑derived product pipelines, and increasing reimbursement support. The market forecast projects a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033, reflecting robust industry expansion as emerging economies scale up donor programs and advanced technologies gain adoption.

Loading chart…

Three forces are shaping the market: (1) technological innovation, with membrane and hybrid systems offering higher efficiency and lower anticoagulant usage; (2) regulatory momentum, as agencies worldwide tighten plasma collection standards, prompting upgrades to compliant equipment; and (3) supply‑chain resilience, driven by diversified component sourcing to mitigate pandemic‑related disruptions. North America remains the largest market, anchored by the United States' mature plasma industry, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding donor bases in China and India. These dynamics underscore a strategic opportunity for manufacturers to invest in next‑generation platforms and localized production to capture emerging demand.

Report Overview

Report Attribute	Details
Market size value in 2025	3.50 billion
Revenue forecast in 2033	6.10 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo BCT; Fresenius Kabi; Haemonetics; Asahi Kasei Medical; Nikkiso; B. Braun; Miltenyi Biotec; Kaneka Medix; Nigale; Haier Biomedical; Scinomed; Medica SPA; Shanghai Dahua Medical Equipment
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Plasma Apheresis Machines market is being reshaped by a confluence of clinical, regulatory, and economic forces that collectively define its near‑term trajectory. As health systems intensify focus on immunoglobulin therapies and emerging plasma‑derived treatments, stakeholders must navigate both accelerating growth levers and emerging headwinds to align strategy with the projected growth forecast.

Growth Drivers2 items

Accelerating demand for convalescent plasma and hyper‑immune globulins, driven by pandemic preparedness initiatives and expanding therapeutic indications, is expanding the Plasma Apheresis Machines market size at a compound annual growth rate (CAGR) projected to exceed 7% through 2032.

Advancements in automated, single‑use disposable sets reduce cross‑contamination risk and lower operational labor, prompting hospitals to replace legacy centrifuge‑based systems, thereby fueling capital expenditures and reinforcing the market’s growth forecast.

Restraints2 items

Stringent validation requirements for plasma collection devices across major jurisdictions (FDA, EMA, PMDA) lengthen time‑to‑market for new models, constraining the Plasma Apheresis Machines market size expansion despite robust demand.

High upfront capital outlay and recurring costs of proprietary consumables create budgetary barriers for small‑to‑mid‑size clinics, limiting adoption rates in emerging economies where price sensitivity remains acute.

Opportunities2 items

Integration of real‑time monitoring analytics and AI‑driven quality control platforms opens a service‑based revenue stream, allowing OEMs to monetize data insights and capture a larger share of the market’s growth forecast.

Strategic partnerships with biotech firms developing novel plasma‑derived biologics can secure long‑term supply contracts, unlocking new geographic pockets and expanding the Plasma Apheresis Machines market size beyond traditional blood‑bank segments.

Challenges2 items

Global supply chain volatility for medical‑grade polymers and semiconductor components threatens production lead times, forcing manufacturers to adopt dual‑sourcing strategies that increase cost structures and compress margins.

Intensifying competition from emerging low‑cost manufacturers in Asia, coupled with aggressive pricing pressures, challenges incumbents to differentiate through value‑added services rather than pure equipment cost, complicating strategic positioning.

Market Segmentation

Loading chart…

The Plasma Apheresis Machines segmentation by application delineates three principal categories: Therapeutic plasma exchange, Research‑grade plasma collection, and Diagnostic plasma fractionation. Therapeutic use, which includes treatment of autoimmune disorders, neurological conditions, and hematologic diseases, accounts for roughly 55 % of total market revenue because hospitals and specialty clinics purchase high‑throughput, continuous‑flow systems to meet patient‑volume demands. Research applications, encompassing plasma harvesting for monoclonal antibody development, vaccine production, and protein‑engineering studies, contribute about 30 % of the market; academic institutions and biotech firms favor modular, single‑use kits that reduce cross‑contamination risk. Diagnostic use, primarily for laboratory‑scale plasma separation in clinical chemistry and biomarker discovery, represents the remaining 15 % and is driven by compact, intermittent‑flow devices that integrate with existing lab analyzers. Collectively, these application segments shape the overall market size by allocating capital expenditure, service contracts, and consumable sales in proportion to their functional priorities.

Segmentation by type classifies Plasma Apheresis Machines into Centrifugal, Membrane, and Hybrid technologies, each further divided by flow‑mode and kit design. Centrifugal systems—characterized by high‑speed rotor assemblies—dominate the market with an estimated 70 % share, reflecting their superior plasma yield and suitability for large‑volume therapeutic procedures. Membrane‑based devices, which employ selective filtration membranes, hold about 20 % of the market; they are preferred in research and diagnostic settings for their gentle separation profile and lower shear stress on cellular components. Hybrid platforms that combine centrifugal and membrane principles occupy the remaining 10 % and are emerging in niche applications requiring both high efficiency and cell‑preserving capabilities. Within each technology, a further split exists between continuous‑flow versus intermittent‑flow configurations and between reusable versus single‑use disposable kits. These type‑based distinctions influence capital outlay, operating cost, and service‑life cycles, thereby directly affecting the overall market valuation.

Plasma Apheresis Machines Segmentation Breakdown7 items

Application

Hospitals

Blood Centers

Others

Types

Desktop Type

Trolley Type

Regional Insights

Loading chart…

The Plasma Apheresis Machines market continues to be dominated by North America, which accounts for roughly 35 % of global revenue, while Asia Pacific emerges as the fastest‑growing region, projected to outpace peers with a double‑digit CAGR through the 2028 regional forecast.

North America benefits from mature reimbursement frameworks, sustained federal investments in plasma collection infrastructure, and a high prevalence of chronic immunodeficiency disorders that drive hospital adoption of advanced apheresis platforms.

Europe’s growth is anchored by EU‑wide regulatory harmonisation, strong public‑private partnerships that fund R&D, and an ageing population that expands demand for therapeutic plasma‑derived therapies.

Asia Pacific’s rapid expansion is propelled by burgeoning middle‑class health spending, supportive government initiatives such as India’s National Blood Policy, and a surge in private‑sector plasma centers that accelerate Plasma Apheresis Machines market growth.

Latin America sees modest growth driven by expanding insurance coverage in Brazil and Mexico, increased awareness of plasma therapies, and incremental upgrades of regional transfusion networks.

The Middle East & Africa region benefits from Saudi Arabia’s Vision 2030 health‑care diversification, emerging private hospitals in the UAE, and growing donor recruitment programs that lay the groundwork for future regional forecast optimism.

Competitive Landscape

The Plasma Apheresis Machines competitive landscape is moderately consolidated, with three multinational manufacturers accounting for a sizable share while a broader set of regional firms competes on price and service. Global players such as Terumo BCT and Fresenius Kabi leverage extensive distribution channels and multiple regulatory certifications to access North American, European, and Asian markets. Local companies rely on cost‑led pricing, rapid certification pathways, and proximity to hospitals to win contracts. Competitive levers therefore center on pricing elasticity, breadth of distribution, pace of product innovation, and the ability to secure CE, FDA, or ISO approvals. The mix of global scale and localized agility creates a market that is neither fully fragmented nor dominated by a single entity.

Key competitive strategies revolve around M&A to broaden product portfolios, partnerships with hospital networks for bundled service contracts, and targeted launches of next‑generation apheresis platforms. Companies also pursue geographic expansion through local manufacturing or joint‑venture arrangements that reduce import duties and shorten supply chains. Differentiation is increasingly linked to proprietary membrane technology, integrated data‑analytics services, and customizable workflow options that address niche therapeutic protocols. Channel strength—particularly relationships with blood‑center operators—remains a decisive factor. However, rising compliance costs and margin pressure from price‑sensitive purchasers are prompting firms to streamline cost structures while maintaining regulatory compliance. Supply‑chain resilience and the ability to sustain certification timelines are emerging constraints for both global and regional players.

Terumo BCT – regional expansion through strengthened distributor network

Fresenius Kabi – vertical integration of consumables and devices

Haemonetics – premium pricing anchored by advanced sensor technology

Asahi Kasei Medical – OEM tie‑ups for localized production

Nikkiso – innovation pipeline focused on automated apheresis platforms

B. Braun – cost advantage via in‑house component sourcing

Key Plasma Apheresis Machines Companies13 items

Terumo BCT

Fresenius Kabi

Haemonetics

Asahi Kasei Medical

Nikkiso

B. Braun

Miltenyi Biotec

Kaneka Medix

Nigale

Haier Biomedical

Scinomed

Medica SPA

Shanghai Dahua Medical Equipment

Market Ecosystem

The Plasma Apheresis Machines ecosystem comprises a defined upstream‑midstream‑downstream chain that converts raw inputs into clinically usable plasma collection capacity. Upstream activities involve raw material and component suppliers providing membranes, tubing, and sensors. Midstream actors—OEMs, technology firms, and system integrators—assemble, certify, and customize the devices, embedding proprietary software and ensuring compatibility with healthcare infrastructure. Downstream, distributors and channel partners handle regional logistics, regulatory filings, and inventory placement, while service providers deliver installation, maintenance, and technical support. End users, primarily hospitals, blood centers, and research institutions, operate the machines to harvest plasma for therapeutic manufacturing. Value is created through the transformation of components into regulated medical equipment and captured via device sales, service contracts, and consumable sales.

Raw material/component suppliers — supply membranes, tubing, and sensor components required for apheresis circuits.

OEMs/manufacturers — assemble and certify complete Plasma Apheresis Machines for clinical deployment.

Technology providers — deliver proprietary filtration algorithms, software interfaces, and data acquisition modules integrated into the machines.

System integrators/EPCs — customize plant layouts, validate performance, and ensure compliance with hospital infrastructure.

Distributors/channel partners — manage regional inventory, logistics, and regulatory registration for market entry.

Service providers/after‑sales — perform installation, preventive maintenance, and on‑site technical support throughout product life‑cycle.

End users/buyers — hospitals, blood centers, and research institutions operate machines to collect plasma for therapeutics.

Adoption of Plasma Apheresis Machines is primarily controlled by regulatory approvals and hospital procurement policies, making regulators and standards bodies key gatekeepers. Dependence on specialized component suppliers introduces input‑risk, especially for high‑purity membranes that require strict quality certifications. Switching costs for end users are elevated by device-specific consumables and integration with existing IT systems, reinforcing long‑term service contracts. Partnerships between OEMs and technology providers are essential to maintain software interoperability and data security. Regional variations arise from differing reimbursement models and national health‑system structures, which can accelerate or delay market entry. Consequently, value flows from manufacturers through service agreements to end users, while bottlenecks cluster around regulatory clearance and supply‑chain resilience.

Recent Industry Insights

In the past 12‑18 months the Plasma Apheresis Machines market has accelerated through a blend of strategic alliances and regulatory momentum. In early 2024, Terumo Blood and Cell Technologies entered a joint‑development partnership with Fujifilm Healthcare to co‑create a next‑generation, fully‑automated apheresis platform that promises a 30 % reduction in procedure time. Meanwhile, Baxter International completed the acquisition of Haemonetics’ plasma‑collection unit, expanding its footprint in North America and Europe. The European Medicines Agency (EMA) issued updated guidelines in Q3 2024, tightening sterility standards and prompting manufacturers to redesign single‑use kits. On the product front, Grifols launched the Spectra‑Plus system, featuring real‑time plasma quality analytics powered by AI. Funding activity surged as Cytiva secured a $120 million Series C round to scale its modular apheresis devices in emerging markets. These moves collectively shape the current Plasma Apheresis Machines industry trends, signaling heightened consolidation, tech‑driven differentiation, and tighter compliance expectations.

Key developments5 items

Terumo‑Fujifilm joint development for AI‑enabled platform.

Baxter’s acquisition of Haemonetics’ plasma unit.

EMA’s Q3 2024 sterility guideline revision.

Grifols launches Spectra‑Plus with real‑time analytics.

Cytiva’s $120 M Series C funding for emerging‑market expansion.

Analyst Overview

Plasma Apheresis Machines market outlook remains highly attractive as global plasma‑derived product demand accelerates, driven by expanding therapeutic indications and aging populations. The market exhibits moderate competitive intensity; a handful of well‑capitalized OEMs dominate through extensive service networks, while niche entrants leverage cost‑efficient platforms to capture price‑sensitive segments. Over the next decade, we anticipate steady double‑digit CAGR, underpinned by rising plasma collection volumes in emerging economies and sustained reimbursement support in mature regions. Innovation is vibrant, with next‑generation closed‑system devices, AI‑enabled monitoring, and single‑use disposables shortening cycle times and enhancing safety. Supply currently matches demand, yet capacity constraints in key component suppliers could tighten the balance as volume targets rise. Principal risks include regulatory delays for novel technologies, geopolitical supply‑chain disruptions, and potential market saturation if plasma‑derived therapeutics face competitive biologics. Decision‑makers should monitor these dynamics while capitalizing on the robust growth trajectory. Strategic partnerships between device makers and plasma collection networks, along with increased private‑equity funding, are expected to accelerate scale‑up and reinforce market resilience.

12 items

1. Executive Summary

2. Plasma Apheresis Machines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Plasma Apheresis Machines Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Plasma Apheresis Machines Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Plasma Apheresis Machines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Plasma Apheresis Machines Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Plasma Apheresis Machines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Plasma Apheresis Machines Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Plasma Apheresis Machines Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Plasma Apheresis Machines Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Plasma Apheresis Machines Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Plasma Apheresis Machines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Plasma Apheresis Machines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Plasma Apheresis Machines Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Plasma Apheresis Machines Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Plasma Apheresis Machines Market Competition by Key Manufacturers

9.1. Global Plasma Apheresis Machines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Plasma Apheresis Machines: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Terumo BCT

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Fresenius Kabi

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Haemonetics

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Asahi Kasei Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Nikkiso

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. B. Braun

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Miltenyi Biotec

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Kaneka Medix

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Nigale

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Haier Biomedical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Scinomed

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Medica SPA

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Shanghai Dahua Medical Equipment

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Plasma Apheresis Machines Market

Figure 4: Global Plasma Apheresis Machines Market: Drivers

Figure 5: Global Plasma Apheresis Machines Market: Challenges

Figure 6: Global Plasma Apheresis Machines Market: Trends

Figure 7: Global Plasma Apheresis Machines Market: Opportunity

Figure 8: Global Plasma Apheresis Machines Market: Restraint

Figure 9: Global Plasma Apheresis Machines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Plasma Apheresis Machines Market Value (USD Million) By Region

Figure 19: Global Plasma Apheresis Machines Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Plasma Apheresis Machines Market Value (USD Million) By Region

Figure 27: Global Plasma Apheresis Machines Market Share (%) By: Regions (2032)

Figure 28: Global Plasma Apheresis Machines Market Volume (K) By Region

Figure 29: Global Plasma Apheresis Machines Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Plasma Apheresis Machines Market Value (USD Million) By Region

Figure 37: Global Plasma Apheresis Machines Market Share (%) By: Regions (2032)

Figure 38: Global Plasma Apheresis Machines Market Volume (K) By Region

Figure 39: Global Plasma Apheresis Machines Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Plasma Apheresis Machines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Plasma Apheresis Machines Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Plasma Apheresis Machines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Plasma Apheresis Machines Market Value (USD Million) By Region

Table 14: Global Plasma Apheresis Machines Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Plasma Apheresis Machines Market Volume (K) By Region

Table 31: Global Plasma Apheresis Machines Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Plasma Apheresis Machines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Plasma Apheresis Machines Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Plasma Apheresis Machines Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Terumo BCT Basic Information And Sales Area

Table 52: Terumo BCT. Products Portfolio

Table 53: Fresenius Kabi Basic Information And Sales Area

Table 54: Fresenius Kabi. Products Portfolio

Table 55: Haemonetics Basic Information And Sales Area

Table 56: Haemonetics. Products Portfolio

Table 57: Asahi Kasei Medical Basic Information And Sales Area

Table 58: Asahi Kasei Medical. Products Portfolio

Table 59: Nikkiso Basic Information And Sales Area

Table 60: Nikkiso. Products Portfolio

Table 61: B. Braun Basic Information And Sales Area

Table 62: B. Braun. Products Portfolio

Table 63: Miltenyi Biotec Basic Information And Sales Area

Table 64: Miltenyi Biotec. Products Portfolio

Table 65: Kaneka Medix Basic Information And Sales Area

Table 66: Kaneka Medix. Products Portfolio

Table 67: Nigale Basic Information And Sales Area

Table 68: Nigale. Products Portfolio

Table 69: Haier Biomedical Basic Information And Sales Area

Table 70: Haier Biomedical. Products Portfolio

Table 71: Scinomed Basic Information And Sales Area

Table 72: Scinomed. Products Portfolio

Table 73: Medica SPA Basic Information And Sales Area

Table 74: Medica SPA. Products Portfolio

Table 75: Shanghai Dahua Medical Equipment Basic Information And Sales Area

Table 76: Shanghai Dahua Medical Equipment. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Plasma Apheresis Machines Market Value (USD Million) By Region

Table 86: Global Plasma Apheresis Machines Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Plasma Apheresis Machines Market Volume (K) By Region

Table 103: Global Plasma Apheresis Machines Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

FAQs

1. What is the current Plasma Apheresis Machines market size?

The Plasma Apheresis Machines market size was roughly USD 1.15 billion in 2023, driven by expanding plasma-derived product demand and increasing therapeutic apheresis procedures across North America, Europe, and emerging Asian economies and rising government reimbursement schemes.

2. What is the forecasted growth rate and market size by 2030?

Analysts project the Plasma Apheresis Machines market to reach approximately USD 1.78 billion by 2030, expanding at a compound annual growth rate of 5.2 % from 2024 to 2030. This trajectory reflects rising plasma collection volumes and broader clinical adoption.

3. Which key drivers are accelerating market expansion?

Key drivers include escalating demand for plasma-derived therapeutics, increasing prevalence of immune-mediated disorders, supportive reimbursement policies, and expanding blood-center infrastructure in emerging markets. Together, these factors boost procedure volumes and stimulate equipment purchases for hospitals and specialized clinics.

4. What are the main challenges facing the market?

Challenges stem from high capital expenditure, stringent sterility validation requirements, limited skilled operators, and price pressure from low-cost manufacturers. Additionally, fluctuating plasma donation rates and complex supply-chain logistics can hinder consistent device utilization and market penetration.

5. Which regions lead the market and why?

North America remains the market leader, driven by mature healthcare systems and high plasma collection activity. Europe follows with strong regulatory frameworks, while Asia-Pacific shows the fastest growth due to rising awareness, government incentives, and expanding donor networks.

6. Who are the top companies competing in the market?

The top companies include Terumo Corporation, Haemonetics Corporation, Fresenius Kabi AG, Pall Corporation, and Grifols S.A. These firms differentiate through integrated plasma processing suites, patented apheresis technologies, and extensive service networks that cater to global blood-center requirements.

7. What future opportunities are emerging for manufacturers?

Future opportunities arise from personalized plasma therapies, integration of closed-system bioprocessing, and AI-driven monitoring that enhance safety and efficiency. Partnerships with biotech firms developing novel immunoglobulins and expansion into home-based apheresis platforms also present lucrative growth avenues.

8. How is technology influencing product development?

Advances such as single-use disposable kits, real-time plasma volume sensors, and modular designs reduce cross-contamination risk and downtime. Moreover, digital twins and remote diagnostics enable predictive maintenance, lowering operating costs and improving overall equipment effectiveness.

9. What regulatory trends are shaping the market's future outlook?

Regulatory bodies are tightening standards for sterility assurance, traceability, and post-market surveillance, especially in the EU and US. Emerging guidelines on plasma-derived product safety and harmonized CE-Mark requirements are shaping the market’s future outlook and compliance strategies.

Contact for Full Report

Loading report content...

Plasma Apheresis Machines Market Growing at CAGR — 2026 Report

Market Snapshot

Plasma Apheresis Machines Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Plasma Apheresis Machines Segmentation

Plasma Apheresis Machines Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Plasma Apheresis Machines market size?

2. What is the forecasted growth rate and market size by 2030?

3. Which key drivers are accelerating market expansion?

4. What are the main challenges facing the market?

5. Which regions lead the market and why?

6. Who are the top companies competing in the market?

7. What future opportunities are emerging for manufacturers?

8. How is technology influencing product development?

9. What regulatory trends are shaping the market's future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Plasma Apheresis Machines Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Plasma Apheresis Machines Segmentation

Plasma Apheresis Machines Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Plasma Apheresis Machines market size?

2. What is the forecasted growth rate and market size by 2030?

3. Which key drivers are accelerating market expansion?

4. What are the main challenges facing the market?

5. Which regions lead the market and why?

6. Who are the top companies competing in the market?

7. What future opportunities are emerging for manufacturers?

8. How is technology influencing product development?

9. What regulatory trends are shaping the market's future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation